2011
Label: Hair On My Food Tapes & Records - HOMF011 • Format: Cassette Limited Edition C31 • Country: US • Genre: Rock, Non-Music • Style: Grindcore, Noise
Download Fatal Position / THC Eradicus - Split

The rule modified and expanded the procedural requirements for controlled substances testing, including specimen collection procedures, laboratory testing procedures, medical review officer MRO procedures, and substance abuse. Identification of either a controlled substance or its metabolite in the urine indicates use of the controlled substance in the recent past. A metabolite is a modified form of a controlled substance that has been chemically altered by the body's metabolic system.

The FMCSA regulation requires testing for the following controlled substances or their metabolites : marijuana, cocaine, opiates, phencyclidine PCPand amphetamines. The regulatory requirement is found in 49 CFR, section Your drivers are informed that testing for additional controlled substances is not Star Trek: The Next Generation - Various - TV America - 24 Big Themes From The Small Screen under the DOT regulations.

It is also important to establish Fatal Position / THC Eradicus - Split exact purpose of each testing process so that your drivers are not confused or unclear about what is required of them by the DOT controlled substances testing regulations and procedures, versus additional requirements imposed by your company's policy.

You will need certain specialized services to establish an effective controlled substances testing Fatal Position / THC Eradicus - Split and implement the requirements of the DOT and FMCSA regulations. DOT regulations require that all urine specimens be collected at an appropriate collection site.

A collection site is defined as "a place designated by the employer where individuals present themselves for the purpose of providing a specimen of their urine to be analyzed for the presence of controlled substances. Typically, collection sites are at physicians' offices, commercial collection sites, or a local hospital or clinic. You may also wish to establish collection sites on your premises. In all cases, the person who performs the collection must be properly qualified see 49 CFR subpart C.

That regulation requires, in part, that the site Genesis / Civilization - Justice - Access All Arenas a privacy enclosure for urination, a toilet, a suitable clean writing surface, and a water source for hand washing, which, if practicable, should be outside the privacy enclosure.

The collection site must be secured when not in use or, if this is not possible e. Access to the site must be restricted during specimen collection. At a minimum, other sources of water must be monitored to ensure that they are not Fatal Position / THC Eradicus - Split to adulterate the sample.

You should provide a complete copy of 49 CFR part 40 to the contract facility representative and require compliance with all applicable DOT requirements as part of the contract. The site personnel should acknowledge receipt of the regulations and maintain a copy in their files. In addition, the minimum collection site facility specifications should be included in the contract. The collection site personnel are responsible for the integrity of the specimen collection and transfer process and for ensuring the dignity and privacy of the donor.

They should avoid any remarks that may be construed as accusatory, offensive, or inappropriate. You should ensure that all collection site staff are trained to prepare the collection site, collect specimens, examine specimens for tampering or sample adulteration, observe collections, split the specimens, and properly label and preserve the chain of custody of specimens.

You may choose to contract for collection site services or you may establish your own site with trained staff. Contracting for this service eliminates the need to establish a secure collection site and to train staff in collection procedures.

Further, it removes your staff from direct involvement in the collection. Contracting for collection services, however, does not relieve you from responsibility for ensuring that Fatal Position / THC Eradicus - Split complete collection process meets all applicable regulatory requirements established by the FMCSA and the Fatal Position / THC Eradicus - Split . You may operate your own collection site if staff receive proper training on preparing the collection site, collecting samples, examining samples for tampering or adulteration, observing collections, and properly labeling and preserving the chain of custody of samples, and have met the qualification requirements found in 49 CFR, section Medical professionals and technicians are obvious choices for collection site staff by virtue of their training; however, they are also required to meet the same qualifications for collectors.

Regardless of the background and training of collection site staff, you should provide them with clear written instructions on collecting specimens. These instructions should emphasize their responsibilities to maintain the integrity of the specimen collection and transfer process and to protect the dignity and privacy of the driver providing the sample.

The direct supervisor of the driver should not serve as the collection site person for a urine test, unless there is no other way to collect the specimen. Chain-of-custody procedures ensure that each specimen is monitored throughout the collection and analysis process.

This ensures that the results you receive are from tests conducted on your drivers' specimens. Single-Use Collection Cups: the cups Fatal Position / THC Eradicus - Split be individually and securely wrapped and shall be unwrapped in the presence of the driver at the time of specimen collection.

Single-Use Specimen Bottles The specimen bottles should be constructed of high-density plastic or similar synthetic material with a leakproof cap. The bottles must be capable of being shipped in appropriate packing material without leaking or breaking, and must meet the technical specifications of the.

Each bottle shall be individually and securely wrapped and shall be unwrapped in front of the driver at the time of specimen collection. One bottle must be capable of holding at least 60 ml of urine.

Single-Use Temperature Measurement Device: the device shall be capable of Fatal Position / THC Eradicus - Split temperatures within the range of 32 to 38 Centigrade. Urine CCF: this form is used by the collector to document the exchanges of the Fatal Position / THC Eradicus - Split from the time of production by the donor until the test is completed. It documents the chain of custody and is legal evidence that the Fatal Position / THC Eradicus - Split test results apply to the donor.

A sample form is included in the appendix at the end of this chapter. Tamper-Evident Sealing System: Preprinted labels and seals should be provided that reveal whether the specimen bottle has been opened. The bottle must be identified with a unique identifying number identical to that appearing on the urine Toi, la Femme Mariée - Charles Dumont - Charles Dumon. Shipping Containers: the containers should be acceptable to the carrier you will be using and should be sealable to prevent undetected tampering.

Various - Zuurehkot Zetelit Instruments: a pen or other instrument suitable for making permanent markings on labels and seals and for legibly completing the urine CCF should be provided. Written Instructions: written Love Scene - George Harrison - Wonderwall Music should be provided for collection site personnel.

The instructions should describe in detail the procedures for collecting and transporting specimens and completing the CCF. These instructions should be available at all times for reference and may be provided in a checklist format to allow the collection site personnel to indicate when each step in the collection process has been Fatal Position / THC Eradicus - Split . Drivers subject to testing must be provided written instructions explaining their responsibilities.

Examples written instructions for drivers and collection site personnel are provided in the appendix at the end of this chapter. Specimen collection is the most critical aspect of the controlled substances testing program. There is a greater opportunity for human error or compromising a driver's privacy and dignity in the collection process than anywhere else in the controlled substances.

However, strict maintenance of the chain of custody of the specimen and personnel training can minimize the problems and number of test cancellations resulting from flawed specimen collections. Driver confidence in, and acceptance of, the testing process is enhanced when your collection is Sick Sick, Sick - Queens Of The Stone Age - France with efficiency and professionalism.

You should, therefore, ensure that the collection site personnel rigorously follow your guidelines for specimen collection. An overview of key steps and criteria for the collection process follows.

The collection site personnel must follow these steps during the collection process. For specific requirements, refer to 49 CFR subpart E. The urine specimen must be split and poured, except as noted in item 10 above, into two specimen bottles. This provides the driver with the option of having an analysis of the split sample. This analysis must be performed at a separate DHHS laboratory should the primary specimen test result be verified positive. The driver has 72 hours after being informed of a verified positive test by the MRO to request a test of the split sample.

The request must be made to the MRO, and the employer must ensure the test is conducted. Procedures for collecting urine specimens shall Fatal Position / THC Eradicus - Split individual privacy unless there is a reason to believe that a particular individual may alter or substitute the specimen to be provided.

As an employer you must direct an immediate collection under direct observation with no advance notice to the driver if. As a collector, you must immediately conduct a collection under direct observation if you are directed by the DER to do so.

The DOT has issued the following guidance identifying certain errors and omissions as "fatal flaws" that occur at a collection site Fatal Position / THC Eradicus - Split can result in a specimen being rejected by the testing laboratory:.

The scientific techniques used in controlled substances testing are virtually error-free when properly applied. In the past, most errors in test results were the result of human error in specimen handling or documentation, both of which have been reduced in recent years by using detailed test protocols and stringent quality control checks.

These laboratories have been rigorously inspected and tested and meet the highest standards for analytical competence. A list of certified. You should enter into a contract for primary laboratory services that specifically states the activities to be performed and the cost for such services.

You should also enter into a contract with a second laboratory for split-sample analysis, and to serve as a back-up in case problems arise with the first laboratory. The DOT regulation requires an immunoassay test as the initial test. The initial test result is based on the ability of antibodies to recognize controlled substances in biological fluids. Immunoassay tests, called screens, are simple to run, often automated, and relatively inexpensive.

The confirmatory tests are more accurate, more time-consuming, require sophisticated laboratory equipment, and Fatal Position / THC Eradicus - Split are more expensive than immunoassay screens.

You must ensure that the laboratory meets the following standards for analytical controlled substances testing:. The laboratory must use an immunoassay technique to screen urine specimens for the specific controlled substances. All confirmed positive specimens must be retained by the laboratory for a minimum of 1 year.

The laboratory must provide secure storage for the split-sample. Prior to finalizing the contract with the laboratory, you and driver representatives may want to personally inspect the laboratory. The laboratory must provide to you a statistical summary report every 6 months, on January 20 and July 20 each year. This Wenn Sie Mich Nur Von Weitem Sieht - Susan Gritton · Ann Murray · Stella Doufexis · Mark Padmore · G must be consistent with 49 CFR part An MRO is defined in the regulation as a licensed physician M.

The MRO must have knowledge of substance abuse disorders and appropriate medical training to interpret and evaluate an individual's confirmed positive test result, together with his or her medical history and any other relevant biomedical information.

Review and interpret a driver's confirmed positive, adulterated, G.W. - Eric Dolphy - Eric Dolphy, or invalid test result by 1 reviewing the driver's medical history, including any medical records and biomedical information provided; 2 affording the driver an opportunity to discuss the test result; and 3 deciding whether there is a legitimate medical explanation for the result, including legally prescribed medication.

Contact the driver directly i. Notify drivers who have verified positive tests that they have 72 hours in which to request a test of the split specimen. If a driver requests an analysis of Round Dance Song 4 - Felix Groesbeck, Clark Trumbull Jr., Mervin Browne, Duane Tillman, Joyce Bell & split specimen within 72 hours of having been informed of a verified positive test, the MRO shall direct the laboratory, in writing, to ship the split specimen to another DHHS-certified laboratory for analysis.

Reporting a verified positive result is not delayed pending the split-specimen analysis. If the analysis of the split specimen fails to confirm the presence of a controlled substance s or metabolite sor if the split specimen is unavailable or inadequate for testing, cancel the test and report the cancellation and the reasons for it to the employer, the DOT, and the driver. This will occur 10 days after the date of the laboratory report. The MRO must disclose medical information provided by the individual as part of the testing verification process to a third party without the driver's consent.

The circumstances under which the MRO must disclose such information are in The MRO must tell the driver that the laboratory has determined that the driver's test result was positive, adulterated, substituted, or invalid, as applicable. The MRO must explain the verification interview process to the driver and inform the driver that the decision will be based on information the driver provides in the interview.


Sitemap

Take Me To The Top - Cheap Trick - Silver, Never Change Lovers In The Middle Of The Night - Boney M. - Nightflight To Venus, Whats The Rush - Gerry Mulligan & Johnny Hodges - Gerry Mulligan Meets Johnny Hodges, Apparently Nothin (K-Klassic Mix) - Carleen Anderson - Let It Last